A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198
Clinical trial NCT04691180 · COMPLETED
Trial details
- NCT number
- NCT04691180
- Sponsor
- Brii Biosciences Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-05
- Primary completion
- 2021-09-16
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.